nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—Vestibular disorder—Riluzole—amyotrophic lateral sclerosis	0.0275	0.0402	CcSEcCtD
Eszopiclone—Uterine haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0158	0.0231	CcSEcCtD
Eszopiclone—Hyperacusis—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0217	CcSEcCtD
Eszopiclone—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.0145	0.0212	CcSEcCtD
Eszopiclone—Pyelonephritis—Riluzole—amyotrophic lateral sclerosis	0.0145	0.0212	CcSEcCtD
Eszopiclone—TSPO—hindlimb—amyotrophic lateral sclerosis	0.0132	0.0825	CbGeAlD
Eszopiclone—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.013	0.019	CcSEcCtD
Eszopiclone—Hernia—Riluzole—amyotrophic lateral sclerosis	0.0118	0.0172	CcSEcCtD
Eszopiclone—TSPO—appendage—amyotrophic lateral sclerosis	0.0113	0.0707	CbGeAlD
Eszopiclone—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0165	CcSEcCtD
Eszopiclone—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0162	CcSEcCtD
Eszopiclone—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0154	CcSEcCtD
Eszopiclone—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0154	CcSEcCtD
Eszopiclone—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00998	0.0146	CcSEcCtD
Eszopiclone—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.0095	0.0139	CcSEcCtD
Eszopiclone—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00879	0.0128	CcSEcCtD
Eszopiclone—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00843	0.0123	CcSEcCtD
Eszopiclone—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00818	0.012	CcSEcCtD
Eszopiclone—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00788	0.0115	CcSEcCtD
Eszopiclone—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0078	0.0114	CcSEcCtD
Eszopiclone—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00773	0.0113	CcSEcCtD
Eszopiclone—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00773	0.0113	CcSEcCtD
Eszopiclone—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00766	0.0112	CcSEcCtD
Eszopiclone—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00766	0.0112	CcSEcCtD
Eszopiclone—Stupor—Riluzole—amyotrophic lateral sclerosis	0.0074	0.0108	CcSEcCtD
Eszopiclone—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0074	0.0108	CcSEcCtD
Eszopiclone—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00715	0.0105	CcSEcCtD
Eszopiclone—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.0071	0.0444	CbGeAlD
Eszopiclone—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00687	0.01	CcSEcCtD
Eszopiclone—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00656	0.00959	CcSEcCtD
Eszopiclone—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00648	0.0406	CbGeAlD
Eszopiclone—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00642	0.00939	CcSEcCtD
Eszopiclone—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00633	0.00925	CcSEcCtD
Eszopiclone—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00629	0.00919	CcSEcCtD
Eszopiclone—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00627	0.0392	CbGeAlD
Eszopiclone—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00624	0.00912	CcSEcCtD
Eszopiclone—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00616	0.009	CcSEcCtD
Eszopiclone—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00607	0.00888	CcSEcCtD
Eszopiclone—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00607	0.00888	CcSEcCtD
Eszopiclone—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00603	0.00882	CcSEcCtD
Eszopiclone—Gout—Riluzole—amyotrophic lateral sclerosis	0.00592	0.00865	CcSEcCtD
Eszopiclone—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00584	0.00854	CcSEcCtD
Eszopiclone—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00566	0.00827	CcSEcCtD
Eszopiclone—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00562	0.00822	CcSEcCtD
Eszopiclone—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00552	0.00807	CcSEcCtD
Eszopiclone—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00552	0.00807	CcSEcCtD
Eszopiclone—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00546	0.00798	CcSEcCtD
Eszopiclone—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00546	0.00798	CcSEcCtD
Eszopiclone—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00539	0.00789	CcSEcCtD
Eszopiclone—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00533	0.0078	CcSEcCtD
Eszopiclone—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00533	0.0078	CcSEcCtD
Eszopiclone—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00519	0.00758	CcSEcCtD
Eszopiclone—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00507	0.00742	CcSEcCtD
Eszopiclone—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00708	CcSEcCtD
Eszopiclone—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00479	0.00701	CcSEcCtD
Eszopiclone—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00475	0.00694	CcSEcCtD
Eszopiclone—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.0047	0.00687	CcSEcCtD
Eszopiclone—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.0047	0.00687	CcSEcCtD
Eszopiclone—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00457	0.00667	CcSEcCtD
Eszopiclone—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00446	0.00652	CcSEcCtD
Eszopiclone—Injury—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00638	CcSEcCtD
Eszopiclone—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00632	CcSEcCtD
Eszopiclone—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00427	0.00624	CcSEcCtD
Eszopiclone—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00427	0.00624	CcSEcCtD
Eszopiclone—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00421	0.00616	CcSEcCtD
Eszopiclone—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00413	0.00603	CcSEcCtD
Eszopiclone—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00407	0.0255	CbGeAlD
Eszopiclone—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00401	0.00586	CcSEcCtD
Eszopiclone—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00401	0.00586	CcSEcCtD
Eszopiclone—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00398	0.00581	CcSEcCtD
Eszopiclone—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00577	CcSEcCtD
Eszopiclone—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00577	CcSEcCtD
Eszopiclone—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00566	CcSEcCtD
Eszopiclone—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.0038	0.00555	CcSEcCtD
Eszopiclone—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00551	CcSEcCtD
Eszopiclone—TSPO—embryo—amyotrophic lateral sclerosis	0.00375	0.0235	CbGeAlD
Eszopiclone—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00373	0.00545	CcSEcCtD
Eszopiclone—GABRA2—brainstem—amyotrophic lateral sclerosis	0.00372	0.0233	CbGeAlD
Eszopiclone—GABRG3—nervous system—amyotrophic lateral sclerosis	0.00365	0.0229	CbGeAlD
Eszopiclone—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00533	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00528	CcSEcCtD
Eszopiclone—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00359	0.0225	CbGeAlD
Eszopiclone—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00355	0.00519	CcSEcCtD
Eszopiclone—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00517	CcSEcCtD
Eszopiclone—GABRG3—central nervous system—amyotrophic lateral sclerosis	0.00352	0.022	CbGeAlD
Eszopiclone—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00507	CcSEcCtD
Eszopiclone—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00507	CcSEcCtD
Eszopiclone—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00347	0.00507	CcSEcCtD
Eszopiclone—TSPO—brainstem—amyotrophic lateral sclerosis	0.00344	0.0215	CbGeAlD
Eszopiclone—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00487	CcSEcCtD
Eszopiclone—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00474	CcSEcCtD
Eszopiclone—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00468	CcSEcCtD
Eszopiclone—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00319	0.00467	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00462	CcSEcCtD
Eszopiclone—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00461	CcSEcCtD
Eszopiclone—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00458	CcSEcCtD
Eszopiclone—Depression—Riluzole—amyotrophic lateral sclerosis	0.00308	0.0045	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00303	0.00443	CcSEcCtD
Eszopiclone—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0044	CcSEcCtD
Eszopiclone—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.003	0.00439	CcSEcCtD
Eszopiclone—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00433	CcSEcCtD
Eszopiclone—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00295	0.00431	CcSEcCtD
Eszopiclone—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00291	0.00426	CcSEcCtD
Eszopiclone—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00284	0.0177	CbGeAlD
Eszopiclone—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00284	0.0177	CbGeAlD
Eszopiclone—GABRA5—nervous system—amyotrophic lateral sclerosis	0.00281	0.0176	CbGeAlD
Eszopiclone—GABRG3—brain—amyotrophic lateral sclerosis	0.00279	0.0175	CbGeAlD
Eszopiclone—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00406	CcSEcCtD
Eszopiclone—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00405	CcSEcCtD
Eszopiclone—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00403	CcSEcCtD
Eszopiclone—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00403	CcSEcCtD
Eszopiclone—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00402	CcSEcCtD
Eszopiclone—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00399	CcSEcCtD
Eszopiclone—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.0027	0.0169	CbGeAlD
Eszopiclone—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00383	CcSEcCtD
Eszopiclone—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00261	0.0164	CbGeAlD
Eszopiclone—GABRA4—nervous system—amyotrophic lateral sclerosis	0.00255	0.0159	CbGeAlD
Eszopiclone—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00253	0.0158	CbGeAlD
Eszopiclone—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00253	0.0158	CbGeAlD
Eszopiclone—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00252	0.0158	CbGeAlD
Eszopiclone—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.0025	0.0157	CbGeAlD
Eszopiclone—Chills—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00364	CcSEcCtD
Eszopiclone—GABRA4—central nervous system—amyotrophic lateral sclerosis	0.00245	0.0153	CbGeAlD
Eszopiclone—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00358	CcSEcCtD
Eszopiclone—TSPO—medulla oblongata—amyotrophic lateral sclerosis	0.0024	0.015	CbGeAlD
Eszopiclone—GABRA4—cerebellum—amyotrophic lateral sclerosis	0.0024	0.015	CbGeAlD
Eszopiclone—Tension—Riluzole—amyotrophic lateral sclerosis	0.00237	0.00346	CcSEcCtD
Eszopiclone—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00346	CcSEcCtD
Eszopiclone—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00343	CcSEcCtD
Eszopiclone—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00341	CcSEcCtD
Eszopiclone—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00339	CcSEcCtD
Eszopiclone—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00331	CcSEcCtD
Eszopiclone—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00327	CcSEcCtD
Eszopiclone—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00223	0.014	CbGeAlD
Eszopiclone—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00326	CcSEcCtD
Eszopiclone—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00324	CcSEcCtD
Eszopiclone—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00322	CcSEcCtD
Eszopiclone—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00318	CcSEcCtD
Eszopiclone—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00317	CcSEcCtD
Eszopiclone—GABRA5—brain—amyotrophic lateral sclerosis	0.00215	0.0134	CbGeAlD
Eszopiclone—TSPO—spinal cord—amyotrophic lateral sclerosis	0.00214	0.0134	CbGeAlD
Eszopiclone—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00312	CcSEcCtD
Eszopiclone—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00213	0.0133	CbGeAlD
Eszopiclone—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00213	0.0133	CbGeAlD
Eszopiclone—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00209	0.00306	CcSEcCtD
Eszopiclone—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00305	CcSEcCtD
Eszopiclone—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00206	0.003	CcSEcCtD
Eszopiclone—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00206	0.003	CcSEcCtD
Eszopiclone—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00205	0.0128	CbGeAlD
Eszopiclone—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00205	0.0128	CbGeAlD
Eszopiclone—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00299	CcSEcCtD
Eszopiclone—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00297	CcSEcCtD
Eszopiclone—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00294	CcSEcCtD
Eszopiclone—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00201	0.0125	CbGeAlD
Eszopiclone—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.00201	0.0125	CbGeAlD
Eszopiclone—GABRA3—brain—amyotrophic lateral sclerosis	0.002	0.0125	CbGeAlD
Eszopiclone—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0029	CcSEcCtD
Eszopiclone—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00288	CcSEcCtD
Eszopiclone—Infection—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00286	CcSEcCtD
Eszopiclone—GABRA4—brain—amyotrophic lateral sclerosis	0.00195	0.0122	CbGeAlD
Eszopiclone—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00195	0.0122	CbGeAlD
Eszopiclone—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00281	CcSEcCtD
Eszopiclone—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00278	CcSEcCtD
Eszopiclone—GABRA1—nervous system—amyotrophic lateral sclerosis	0.00188	0.0118	CbGeAlD
Eszopiclone—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00275	CcSEcCtD
Eszopiclone—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.00187	0.0117	CbGeAlD
Eszopiclone—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00183	0.0115	CbGeAlD
Eszopiclone—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00181	0.0113	CbGeAlD
Eszopiclone—TSPO—nervous system—amyotrophic lateral sclerosis	0.0018	0.0113	CbGeAlD
Eszopiclone—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00262	CcSEcCtD
Eszopiclone—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00261	CcSEcCtD
Eszopiclone—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00177	0.0111	CbGeAlD
Eszopiclone—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00259	CcSEcCtD
Eszopiclone—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00257	CcSEcCtD
Eszopiclone—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00256	CcSEcCtD
Eszopiclone—TSPO—central nervous system—amyotrophic lateral sclerosis	0.00174	0.0109	CbGeAlD
Eszopiclone—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00254	CcSEcCtD
Eszopiclone—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0025	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00249	CcSEcCtD
Eszopiclone—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00248	CcSEcCtD
Eszopiclone—TSPO—cerebellum—amyotrophic lateral sclerosis	0.0017	0.0106	CbGeAlD
Eszopiclone—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00246	CcSEcCtD
Eszopiclone—Pain—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00246	CcSEcCtD
Eszopiclone—GABRB2—brain—amyotrophic lateral sclerosis	0.00163	0.0102	CbGeAlD
Eszopiclone—GABRG2—brain—amyotrophic lateral sclerosis	0.00163	0.0102	CbGeAlD
Eszopiclone—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00237	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00236	CcSEcCtD
Eszopiclone—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00229	CcSEcCtD
Eszopiclone—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00228	CcSEcCtD
Eszopiclone—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00228	CcSEcCtD
Eszopiclone—GABRA2—brain—amyotrophic lateral sclerosis	0.00149	0.00931	CbGeAlD
Eszopiclone—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00212	CcSEcCtD
Eszopiclone—GABRA1—brain—amyotrophic lateral sclerosis	0.00144	0.009	CbGeAlD
Eszopiclone—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00207	CcSEcCtD
Eszopiclone—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00204	CcSEcCtD
Eszopiclone—TSPO—brain—amyotrophic lateral sclerosis	0.00138	0.00862	CbGeAlD
Eszopiclone—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00197	CcSEcCtD
Eszopiclone—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.0013	0.0019	CcSEcCtD
Eszopiclone—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00183	CcSEcCtD
Eszopiclone—Rash—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00182	CcSEcCtD
Eszopiclone—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00181	CcSEcCtD
Eszopiclone—Headache—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0018	CcSEcCtD
Eszopiclone—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.00119	0.00745	CbGeAlD
Eszopiclone—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00171	CcSEcCtD
Eszopiclone—PTGS1—nervous system—amyotrophic lateral sclerosis	0.001	0.00628	CbGeAlD
Eszopiclone—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000966	0.00604	CbGeAlD
Eszopiclone—CYP2C8—brain—amyotrophic lateral sclerosis	0.000945	0.00592	CbGeAlD
Eszopiclone—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000838	0.00524	CbGeAlD
Eszopiclone—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000807	0.00505	CbGeAlD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000779	0.00499	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000767	0.00491	CbGpPWpGaD
Eszopiclone—PTGS1—brain—amyotrophic lateral sclerosis	0.000767	0.0048	CbGeAlD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000754	0.00483	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000742	0.00475	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000735	0.00471	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000732	0.00469	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000724	0.00464	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000724	0.00464	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000721	0.00462	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000717	0.00459	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000717	0.00459	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000708	0.00454	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000697	0.00447	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000696	0.00446	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000696	0.00446	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000684	0.00438	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000679	0.00435	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000675	0.00433	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000674	0.00432	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000672	0.0043	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000666	0.00427	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000666	0.00427	CbGpPWpGaD
Eszopiclone—PTGS1—Eicosanoid Synthesis—PTGS2—amyotrophic lateral sclerosis	0.000659	0.00422	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000655	0.0042	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000655	0.0042	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000652	0.00418	CbGpPWpGaD
Eszopiclone—PTGS1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00065	0.00416	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000645	0.00413	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000643	0.00412	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000637	0.00408	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000625	0.00401	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000622	0.00398	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000616	0.00395	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000615	0.00394	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000609	0.0039	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000609	0.0039	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0006	0.00385	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0006	0.00384	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000599	0.00383	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000597	0.00382	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000594	0.00381	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000594	0.00381	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000594	0.00381	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000594	0.0038	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000593	0.0038	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000592	0.00379	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000592	0.00379	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000588	0.00377	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000581	0.00372	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000581	0.00372	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000578	0.0037	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000573	0.00367	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000571	0.00366	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000571	0.00366	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000569	0.00364	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000563	0.00361	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000557	0.00357	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000557	0.00357	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000555	0.00355	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000555	0.00355	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000552	0.00354	CbGpPWpGaD
Eszopiclone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.000552	0.00353	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000549	0.00352	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000549	0.00352	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000544	0.00349	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000543	0.00348	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000542	0.00347	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000533	0.00342	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000533	0.00342	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000528	0.00338	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000524	0.00336	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000524	0.00336	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00052	0.00333	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000518	0.00332	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000515	0.0033	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000511	0.00327	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000511	0.00327	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000509	0.00326	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000502	0.00322	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000502	0.00322	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000501	0.00321	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000497	0.00318	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000494	0.00317	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000493	0.00316	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000488	0.00313	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000487	0.00312	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000487	0.00312	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000479	0.00307	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000471	0.00302	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000467	0.00299	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000467	0.00299	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000461	0.00295	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000459	0.00294	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000458	0.00294	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000455	0.00292	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000455	0.00291	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000454	0.00291	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000454	0.00291	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000453	0.0029	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000445	0.00285	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000445	0.00285	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000445	0.00285	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000439	0.00281	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000438	0.0028	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000438	0.0028	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000437	0.0028	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000434	0.00278	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00043	0.00275	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000427	0.00274	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000427	0.00274	CbGpPWpGaD
Eszopiclone—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00042	0.00269	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000419	0.00268	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000416	0.00267	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000414	0.00265	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000404	0.00259	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000402	0.00257	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000397	0.00254	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00039	0.0025	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000385	0.00247	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000381	0.00244	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00038	0.00243	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000373	0.00239	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000373	0.00239	CbGpPWpGaD
Eszopiclone—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000367	0.00235	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000366	0.00235	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000362	0.00232	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000351	0.00225	CbGpPWpGaD
Eszopiclone—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000342	0.00219	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000333	0.00213	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000323	0.00207	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000309	0.00198	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000307	0.00197	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000298	0.00191	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000298	0.00191	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000295	0.00189	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000293	0.00187	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000287	0.00184	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000282	0.0018	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000277	0.00177	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000274	0.00176	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000274	0.00176	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00027	0.00173	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000268	0.00171	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000266	0.0017	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000263	0.00169	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000251	0.00161	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000251	0.00161	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000249	0.00159	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000248	0.00159	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000245	0.00157	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000244	0.00156	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000244	0.00156	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000239	0.00153	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000239	0.00153	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000238	0.00153	CbGpPWpGaD
Eszopiclone—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000237	0.00152	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000236	0.00151	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000235	0.00151	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000235	0.00151	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000234	0.0015	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000233	0.00149	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00023	0.00147	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00023	0.00147	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000224	0.00143	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000218	0.0014	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000217	0.00139	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000213	0.00137	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00021	0.00134	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000205	0.00131	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000204	0.00131	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000203	0.0013	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000202	0.00129	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000202	0.00129	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000201	0.00129	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000201	0.00129	CbGpPWpGaD
Eszopiclone—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000193	0.00123	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00019	0.00122	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000188	0.00121	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000185	0.00118	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000179	0.00115	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000172	0.0011	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00017	0.00109	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000168	0.00107	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000161	0.00103	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00016	0.00103	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000154	0.000984	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000146	0.000935	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000138	0.000887	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000137	0.000875	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00013	0.000836	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.00013	0.000835	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00013	0.000835	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00013	0.000835	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000122	0.000778	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000119	0.000764	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000111	0.00071	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000111	0.000708	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000106	0.00068	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000106	0.00068	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000104	0.000667	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000102	0.000654	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.89e-05	0.000634	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	9.7e-05	0.000622	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	9.42e-05	0.000604	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.29e-05	0.000595	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.13e-05	0.000585	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.02e-05	0.000578	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9e-05	0.000577	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	8.48e-05	0.000543	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.38e-05	0.000537	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	7.67e-05	0.000491	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.64e-05	0.00049	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	7.14e-05	0.000457	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	7e-05	0.000448	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	7e-05	0.000448	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	6.59e-05	0.000422	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	6.4e-05	0.00041	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	6e-05	0.000384	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.95e-05	0.000381	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	5.81e-05	0.000372	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.59e-05	0.000358	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	5.41e-05	0.000347	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	5.36e-05	0.000344	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.24e-05	0.000336	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	5.06e-05	0.000324	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.94e-05	0.000316	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.88e-05	0.000313	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.5e-05	0.000288	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.4e-05	0.000282	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.14e-05	0.000265	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.02e-05	0.000257	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.83e-05	0.000246	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.54e-05	0.000227	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	3.4e-05	0.000218	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.38e-05	0.000217	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.91e-05	0.000186	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.9e-05	0.000186	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.75e-05	0.000176	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.67e-05	0.000171	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.37e-05	0.000152	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.33e-05	0.000149	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	2.2e-05	0.000141	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.18e-05	0.000139	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.79e-05	0.000115	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.56e-05	0.0001	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.51e-05	9.65e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.43e-05	9.19e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.23e-05	7.86e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.18e-05	7.56e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.09e-06	5.18e-05	CbGpPWpGaD
